Skip to main content
NG

NOVA Genomics

NOVA Genomics offers advanced preimplantation genetic testing (PGT) services, including PGT-A, PGT-M, and PGT-SR, to IVF providers and patients. Their platform leverages cutting-edge technology to deliver high-precision genetic insights, improving accuracy and expanding access to critical reproductive genetic testing.

Founded 20253100+ followers
Updated 3 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Traditional preimplantation genetic testing (PGT) methods can be limited by outdated laboratory technologies, concerns regarding quality and compliance, and ongoing debates about clinical utility. This can restrict access to advanced genetic services for families undergoing IVF.

Solution

NOVA Genomics is developing an advanced platform to provide high-precision preimplantation genetic testing (PGT) services, including PGT-A, PGT-M, and PGT-SR. The company aims to enhance accuracy and clinical impact by leveraging cutting-edge technology and establishing a new standard of care in reproductive genetic testing. This approach is designed to support informed decision-making for IVF journeys by delivering clinically meaningful genetic insights. NOVA Genomics focuses on expanding access to these critical services for patients and IVF providers.

Target Audience

The primary customers are IVF providers and patients undergoing fertility treatments who require advanced genetic screening of embryos to inform clinical decisions and reproductive planning.

Features

  • Comprehensive PGT services including PGT-A (aneuploidy screening), PGT-M (monogenic disorders), and PGT-SR (structural rearrangements).
  • Advanced platform development focused on high-quality genetic insights and accuracy.
  • Commitment to expanding access to genetic services for patients and IVF providers.
  • Emphasis on scientific excellence, patient-centered care, and uncompromising standards in genetic testing.
  • Integration of cutting-edge technology and strategic partnerships with reagent and software providers.
  • Focus on educating customers and the broader community about PGT science and benefits.
  • Collaboration with genetic counseling services for patient support and education.
This profile is AI-generated and may contain inaccuracies.